Concepedia

Phillip M. Galbo

PM

Statistics

Publications

25

Citations

1.9K

H-Index

21

Active since

2017

Affiliations

Albert Einstein College of Medicine(Current)

Roswell Park Comprehensive Cancer Center

Icahn School of Medicine at Mount Sinai

The University of Texas Southwestern Medical Center

University of Arkansas for Medical Sciences

Phillip M. Galbo is an author at Albert Einstein College of Medicine specializing in oncology, medicine, and molecular oncology.

Publications per year

2017–2025

25

Publications

25

Molecular Features of Cancer-associated Fibroblast Subtypes and their Implication on Cancer Pathogenesis, Prognosis, and Immunotherapy Resistance

Phillip M. Galbo, Xingxing Zang, Deyou Zheng · Clinical Cancer Research · 2021 · 423 citations · Full text

Medicine, Cancer Biology, Oncology +16

EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer

Katherine L. Morel, Anjali V. Sheahan, Deborah L. Burkhart et al. · Nature Cancer · 2021 · 241 citations · Full text

Medicine, Molecular Biology, Oncology +12

Stigma and Shame Experiences by MSM Who Take PrEP for HIV Prevention: A Qualitative Study

Alex Dubov, Phillip M. Galbo, Frederick L. Altice et al. · American Journal of Men s Health · 2018 · 236 citations · Full text

Public Health, Community Health, Preventive Medicine +17

TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup

David P. Labbé, Christopher J. Sweeney, Myles Brown et al. · Clinical Cancer Research · 2017 · 109 citations · Full text

Medicine, Cancer Biology, Oncology +16

KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target

Wei Yao, Xiaoxin Ren, Phillip M. Galbo et al. · Science Immunology · 2021 · 88 citations · Full text

Medicine, Immunology, Oncology +13

1–5 of 25